[HTML][HTML] Metabolomics in degenerative brain diseases
MQ Escobar, JG de Moraes Pontes, L Tasic - Brain research, 2021 - Elsevier
Among the most studied diseases that affect the central nervous system are Parkinson's,
Alzheimer's, and Huntington's diseases, but the lack of effective biomarkers, accurate …
Alzheimer's, and Huntington's diseases, but the lack of effective biomarkers, accurate …
[HTML][HTML] The structural plasticity of polyglutamine repeats
From yeast to humans, polyglutamine (polyQ) repeat tracts are found frequently in the
proteome and are particularly prominent in the activation domains of transcription factors …
proteome and are particularly prominent in the activation domains of transcription factors …
Drosophila as a Model of Unconventional Translation in Spinocerebellar Ataxia Type 3
SL Johnson, MV Prifti, A Sujkowski, K Libohova… - Cells, 2022 - mdpi.com
RNA toxicity contributes to diseases caused by anomalous nucleotide repeat expansions.
Recent work demonstrated RNA-based toxicity from repeat-associated, non-AUG-initiated …
Recent work demonstrated RNA-based toxicity from repeat-associated, non-AUG-initiated …
Novel Metabolic Biomarkers and Therapeutic Strategies in Neurodegenerative Diseases
A Thapliyal, Shweta, SK Maurya - … : A Major Contributor of Comorbidities in …, 2024 - Springer
Metabolic changes are a major cause of pathophysiological alterations in
neurodegenerative diseases. Recent metabolic profiling studies have led to the …
neurodegenerative diseases. Recent metabolic profiling studies have led to the …
[HTML][HTML] Mechanisms underlying polyglutamine diseases
J Lu - imperialbiosciencereview.wordpress …
Polyglutamine diseases are a group of nine inherited neurodegenerative diseases:
Huntington's disease (HD), Dentato-rubral pallidoluysian atrophy (DRPLA), spinal and …
Huntington's disease (HD), Dentato-rubral pallidoluysian atrophy (DRPLA), spinal and …